Literature DB >> 7012514

Inhibition of the action of sex steroids by gonadotropin-releasing hormone (GnRH) agonists: a new biological effect.

K Sundaram, Y Q Cao, N G Wang, C W Bardin, J Rivier, W Vale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7012514     DOI： 10.1016/0024-3205(81)90369-6

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  11 in total

Review 1.  Histrelin. A review of its pharmacological properties and therapeutic role in central precocious puberty.

Authors:  L B Barradell; D McTavish
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

2.  Antagonists of luteinizing hormone releasing hormone bind to rat mast cells and induce histamine release.

Authors:  K Sundaram; A Didolkar; R Thau; M Chaudhuri; F Schmidt
Journal:  Agents Actions       Date:  1988-12

Review 3.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

4.  New prospects for luteinising hormone releasing hormone as a contraceptive and therapeutic agent.

Authors:  H M Fraser
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-09

5.  Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments.

Authors:  J G Klijn
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

6.  Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer.

Authors:  J G Klijn; F H de Jong; M A Blankenstein; R Docter; J Alexieva-Figusch; J Blonk-van der Wijst; S W Lamberts
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

7.  Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Authors:  G Tolis; D Ackman; A Stellos; A Mehta; F Labrie; A T Fazekas; A M Comaru-Schally; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Inhibition of the growth of some hormone dependent tumors by D-Trp6-LH-RH.

Authors:  A V Schally; T W Redding; A M Comaru-Schally
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

9.  Prostate carcinoma tumor size in rats decreases after administration of antagonists of luteinizing hormone-releasing hormone.

Authors:  T W Redding; D H Coy; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

10.  Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.